BVF »

Sagimet Biosciences Inc-a shares owned by BVF

Quarter-by-quarter ownership of Sagimet Biosciences Inc-a (SGMT) shares owned by BVF from 13F filings

Historical chart of BVF investment in Sagimet Biosciences Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Sagimet Biosciences Inc-a held by BVF consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sagimet Biosciences Inc-a by BVF

Quarter filed Position value Share count Share price at filing
2026-06-30 $19M 2.5M 7.73

More positions owned by BVF

Revolution Medicines (RVMD)
Kymera Therapeutics (KYMR)
Xoma Royalty Corporation Com New (XOMA)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Gh Research Ordinary Shares (GHRS)
Structure Therapeutics Sponsored Ads (GPCR)
Nektar Therapeutics Com New (NKTR)
Mirum Pharmaceuticals (MIRM)
Xencor (XNCR)
Alkermes SHS (ALKS)
Monte Rosa Therapeutics (GLUE)
Cullinan Oncology (CGEM)
Palvella Therapeutics Inc Ne (PVLA)
Zymeworks Del (ZYME)
Kura Oncology (KURA)

View all positions for BVF

Top funds holding Sagimet Biosciences Inc-a

Balyasny Asset Management
Woodline Partners
Silverarc Capital Management
Vanguard Capital Management
BVF
Affinity Asset Advisors
Federated Investors
Dr. Jeffrey R. Jay, M.D.
Geode Capital Management
Blue Owl Capital Holdings
Baker Bros. Advisors
Millennium Management
Standard Life Aberdeen
BlackRock
Goldman Sachs Group

View all funds holding Sagimet Biosciences Inc-a